Attention-Deficit/Hyperactivity Disorder as a Metabolic Encephalopathy
Author:
Russell Vivienne Ann
Publisher
Springer New York
Reference160 articles.
1. Abikoff H. B., Jensen P. S., Arnold L. L., Hoza B., Hechtman L., Pollack S., Martin D., Alvir J., March J. S., Hinshaw S., Vitiello B., Newcorn J., Greiner A., Cantwell D. P., Conners C. K., Elliott G., Greenhill L. L., Kraemer H., Pelham W. E., Jr., Severe J. B., Swanson J. M., Wells K. and Wigal T. 2002. Observed classroom behavior of children with ADHD: Relationship to gender and comorbidity. J. Abnorm. Child Psychol. 30:349–359 2. Adewuya A. O. and Famuyiwa O. O. 2006. Attention deficit hyperactivity disorder among Nigerian primary school children: Prevalence and co-morbid conditions. Eur. Child Adolesc. Psychiatr. 16:10–15.Epub 28 November 2006 3. Adriani W., Canese R., Podo F. and Laviola G. 2006a. 1H MRS-detectable metabolic brain changes and reduced impulsive behavior in adult rats exposed to methylphenidate during adolescence. Neurotoxicol. Teratol. 29:116–125.Epub 6 December 2006 4. Adriani W., Leo D., Guarino M., Natoli A., Di C. E., De A. G., Traina E., Testai E., Perrone-Capano C. and Laviola G. 2006b. Short-term effects of adolescent methylphenidate exposure on brain striatal gene expression and sexual/endocrine parameters in male rats. Ann. N. Y. Acad. Sci. 1074:52–73 5. American Academy of Pediatrics 2000. Clinical practice guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 105:1158–1170
|
|